In contrast, somatic mutation of PTPRD leads to increased STAT3 activation in HNSCC tumors and cell lines, concomitant with increased cell growth and sensitivity to STAT3 pathway inhibition. The gene discussed is STAT3; the disease is head and neck squamous cell carcinoma.